Dr. Matthew T. Stepanovich

Kelly Walkovich is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Walkovich is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Dr. Biermann serves as Director of the Musculoskeletal Oncology Program at the University of Michigan. Her clinical interests include malignant and benign tumors of soft tissue and bone, both primary and metastatic. Her practice includes both adults and children. Dr. Biermann chairs the Multidisciplinary Sarcoma Tumor Board, a collaborative cancer center group including medical and pediatric oncologists, pathologist, diagnostic radiologists, and radiation therapists. The Sarcoma clinic meets weekly. The University of Michigan Sarcoma team engages in patient care, clinical trials, and basic science research. In addition to her regional responsibilities, Dr. Biermann has been active in national committee and administrative work. She chairs the National Comprehensive Cancer Network (NCCN) Bone Tumors Panel. She is past president of the Musculoskeletal Tumor Society (MSTS). She is a member of the American Society of Clinical Oncology (ASCO). She sits on the Orthopaedic Research and Education Foundation (OREF) Grant Board. Her active research program has included more than 87 publications in the areas of musculoskeletal tumors and in the impact of the Internet on patient education. Dr. Biermann is the University of Michigan Medical Director for the Sarcoma Program and the Orthopaedic Surgery Residency Program Director. Dr. Biermann is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Bone Tumor, Chondrosarcoma, Osteosarcoma, and Hip Replacement. Dr. Biermann is board certified in Orthopedic Surgery.

Dr. Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and currently as Chair of the Medical and Scientific Advisory Committee to the National Hemophilia Foundation. Dr. Pipe is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilia B, Blood Clots, and Von Willebrand Disease (VWD).